logo
Plus   Neg
Share
Email

Alexion Rejects Elliott Recommendation - Quick Facts

Alexion Pharmaceuticals, Inc. (ALXN) said the company has recently engaged in good faith with Elliott Advisors (UK) Limited, an affiliate of Elliott Management, to listen their recommendation that Alexion Pharma immediately launch a proactive sale process. The Board of Alexion Pharma unanimously decided that conducting a proactive sale process would not be in the best interest of shareholders.

Alexion Pharma said its Board considered, among other factors, that it is highly unusual for a biopharmaceutical company of its size to proactively launch a sale process.

Alexion also noted that it has not received any indications of interest to acquire the
company nor it has rejected any such inbound proposals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.
Follow RTT